US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

16.000
-0.590-3.56%

Close Jun 14 16:00 ET

16.000
0.0000.00%

Post 16:00 ET

411.57MMarket Cap-124031P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

50M

Operating revenue

--0

--50M

--0

Cost of revenue

Gross profit

Operating expense

94.13%9.93M

49.31%33.92M

77.57%9.68M

5.12M

-20.69%22.72M

5.45M

28.65M

Selling and administrative expenses

45.11%2.15M

8.48%6.32M

11.30%1.66M

--1.48M

-7.33%5.83M

--1.5M

--6.29M

-General and administrative expense

45.11%2.15M

8.48%6.32M

11.30%1.66M

--1.48M

-7.33%5.83M

--1.5M

--6.29M

Research and development costs

114.15%7.78M

63.39%27.6M

102.63%8.01M

--3.63M

-24.45%16.89M

--3.95M

--22.36M

Operating profit

-94.13%-9.93M

170.76%16.08M

-77.57%-9.68M

-5.12M

20.69%-22.72M

-5.45M

-28.65M

Net non-operating interest income expense

429.45%1.64M

1,079.09%4.4M

642.74%1.79M

309K

246.27%373K

241K

-255K

Non-operating interest income

307.98%1.64M

505.26%4.61M

423.39%1.79M

--401K

888.31%761K

--342K

--77K

Non-operating interest expense

--0

-46.39%208K

--0

--92K

16.87%388K

--101K

--332K

Other net income (expense)

-583.33%-123K

241.40%2.7M

98.09%-44K

-18K

-1,825.25%-1.91M

-2.3M

-99K

Gain on sale of security

---117K

66.67%5K

200.00%3K

----

50.00%3K

---3K

--2K

Special income (charges)

----

257.79%2.87M

--0

----

-18,070.00%-1.82M

---2.29M

---10K

-Less:Other special charges

----

-257.79%-2.87M

--0

----

18,070.00%1.82M

--2.29M

--10K

Other non- operating income (expenses)

66.67%-6K

-92.39%-177K

-370.00%-47K

---18K

-1.10%-92K

---10K

---91K

Income before tax

-74.48%-8.42M

195.53%23.17M

-5.56%-7.93M

-4.82M

16.37%-24.25M

-7.51M

-29M

Income tax

450K

-161K

Net income

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

-4.82M

16.37%-24.25M

-7.51M

-29M

Net income continuous Operations

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

---4.82M

16.37%-24.25M

---7.51M

---29M

Minority interest income

Net income attributable to the parent company

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

-4.82M

16.37%-24.25M

-7.51M

-29M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

-4.82M

16.37%-24.25M

-7.51M

-29M

Basic earnings per share

-7.53%-0.3111

193.50%1.36

36.26%-0.2871

-0.2893

16.37%-1.4545

-0.4505

-1.7393

Diluted earnings per share

-7.53%-0.3111

177.00%1.12

36.26%-0.2871

-0.2893

16.37%-1.4545

-0.4505

-1.7393

Dividend per share

Currency Unit

USD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	50M	0	0	0	0	0
Operating revenue	--0	--50M	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	94.13%9.93M	49.31%33.92M	77.57%9.68M	5.12M	-20.69%22.72M	5.45M	28.65M
Selling and administrative expenses	45.11%2.15M	8.48%6.32M	11.30%1.66M	--1.48M	-7.33%5.83M	--1.5M	--6.29M
-General and administrative expense	45.11%2.15M	8.48%6.32M	11.30%1.66M	--1.48M	-7.33%5.83M	--1.5M	--6.29M
Research and development costs	114.15%7.78M	63.39%27.6M	102.63%8.01M	--3.63M	-24.45%16.89M	--3.95M	--22.36M
Operating profit	-94.13%-9.93M	170.76%16.08M	-77.57%-9.68M	-5.12M	20.69%-22.72M	-5.45M	-28.65M
Net non-operating interest income expense	429.45%1.64M	1,079.09%4.4M	642.74%1.79M	309K	246.27%373K	241K	-255K
Non-operating interest income	307.98%1.64M	505.26%4.61M	423.39%1.79M	--401K	888.31%761K	--342K	--77K
Non-operating interest expense	--0	-46.39%208K	--0	--92K	16.87%388K	--101K	--332K
Other net income (expense)	-583.33%-123K	241.40%2.7M	98.09%-44K	-18K	-1,825.25%-1.91M	-2.3M	-99K
Gain on sale of security	---117K	66.67%5K	200.00%3K	----	50.00%3K	---3K	--2K
Special income (charges)	----	257.79%2.87M	--0	----	-18,070.00%-1.82M	---2.29M	---10K
-Less:Other special charges	----	-257.79%-2.87M	--0	----	18,070.00%1.82M	--2.29M	--10K
Other non- operating income (expenses)	66.67%-6K	-92.39%-177K	-370.00%-47K	---18K	-1.10%-92K	---10K	---91K
Income before tax	-74.48%-8.42M	195.53%23.17M	-5.56%-7.93M	-4.82M	16.37%-24.25M	-7.51M	-29M
Income tax	0	450K	-161K	0	0	0
Net income	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	-4.82M	16.37%-24.25M	-7.51M	-29M
Net income continuous Operations	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	---4.82M	16.37%-24.25M	---7.51M	---29M
Minority interest income
Net income attributable to the parent company	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	-4.82M	16.37%-24.25M	-7.51M	-29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	-4.82M	16.37%-24.25M	-7.51M	-29M
Basic earnings per share	-7.53%-0.3111	193.50%1.36	36.26%-0.2871	-0.2893	16.37%-1.4545	-0.4505	-1.7393
Diluted earnings per share	-7.53%-0.3111	177.00%1.12	36.26%-0.2871	-0.2893	16.37%-1.4545	-0.4505	-1.7393
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall